LWMNY
AMGN icon

Landmark Wealth Management (New York)’s Amgen AMGN Stock Holding History

Landmark Wealth Management (New York)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$645K Hold
1,780
– – 0.15% 96
2026
Q1 		$626K Buy
+1,780
New +$635K 0.17% 95

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Landmark Wealth Management (New York)'s AMGN Position: Q2 2026 in Review

Landmark Wealth Management (New York) held its Amgen (AMGN) position steady in Q2 2026 at 1,780 shares worth $645K. The position accounts for 0.15% of the portfolio, ranked #96.

Landmark Wealth Management (New York) first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Landmark Wealth Management (New York) held 1,780 shares of Amgen worth $645K as of Q2 2026.
  • Landmark Wealth Management (New York) left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.15% of Landmark Wealth Management (New York)'s portfolio in Q2 2026, its #96 holding.
  • Landmark Wealth Management (New York) first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q2 2026, filed 10 Aug 2026.